Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke

World News: . []

CLEVELAND March 20 2017 GLOBE NEWSWIRE -- Athersys, Inc NASDAQATHX announced today that clinical investigators have published results from Athersys Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients the MA STERS...

More news and information about Athersys, Inc.

Published By:

Globe Newswire: 10:30 GMT Monday 20th March 2017

Published: .

Search for other references to "publications" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers